Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Morgan Stanley (NY:MS)

184.41 -3.67 (-1.95%)
Streaming Delayed Price Updated: 10:12 AM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Morgan Stanley

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand ↗
ResMed (NYSE:RMD) outlined its growth outlook, margin strategy and portfolio plans during a Morgan Stanley discussion, with executives emphasizing demand generation, patient adherence and ongoing... 
Via MarketBeat
News headline image
Why Marvell Stock Rallied Today ↗
The chipmaker announced plans to unveil next-generation technology at an upcoming tech conference. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Moderna (MRNA) Stock Trades Up, Here Is Why
What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.4% in the afternoon session after positive Phase 3 INTerpath-001 trial results ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Tesla Opens Roadster Preorders; More SpaceX Merger Talks Surface ↗
A combined Tesla and SpaceX would dominate physical AI applications, according to Morgan Stanley. Both stocks gained on Monday. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig ↗
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring of... 
Via MarketBeat
News headline image
Morgan Stanley Investment Management's 1GT Leads €49 Million Series E Funding for Amber Electric
From Morgan Stanley Investment Management
Via Business Wire
News headline image
Ardelyx Targets $500M Revenue This Year, Profitability by 2027 ↗
Ardelyx (NASDAQ:ARDX) expects to generate close to $500 million in revenue this year and reach profitability in 2027, supported by continued growth of its IBS-C treatment IBSRELA and hyperphosphatemia... 
Via MarketBeat
News headline image
Cognex Touts AI Vision Growth Across Data Centers, Semis and China ↗
Cognex (NASDAQ:CGNX) Chief Financial Officer Dennis Fehr said the machine-vision company is pursuing growth across logistics, packaging, semiconductors, electronics and data-center supply chains,... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
NeoGenomics Highlights NGS, MRD Growth Strategy at Morgan Stanley Conference ↗
NeoGenomics (NASDAQ:NEO) executives outlined the company’s strategy to expand its role in community-based precision oncology, emphasizing growth in next-generation sequencing, minimal residual disease... 
Via MarketBeat
News headline image
Recursion Pharmaceuticals Highlights AI Drug Platform, FAP Progress at Morgan Stanley Conference ↗
Recursion Pharmaceuticals (NASDAQ:RXRX) outlined its strategy, clinical pipeline and partnership progress at Morgan Stanley’s Global Healthcare Conference, with CEO and President Najat Khan emphasizing... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances ↗
Helus Pharma Chief Executive Officer Michael Halstead said the company expects a pivotal Phase III readout for its HLP003 program in adjunctive major depressive disorder in the fourth quarter,... 
Via MarketBeat
News headline image
Aurora Innovation Targets 20 Driverless Trucks a Week as DaaS Shift Takes Shape ↗
Aurora Innovation (NASDAQ:AUR) is preparing to expand its autonomous-trucking operations through a second-generation hardware rollout, a planned transition toward a driver-as-a-service model and... 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1B ↗
Jazz Pharmaceuticals (NASDAQ:JAZZ) executives outlined the company’s oncology growth strategy, early commercial progress for recently launched therapies and business-development priorities during the... 
Via MarketBeat
Topics Cannabis
News headline image
WW International Eyes Cash Flow Turnaround as GLP-1 Care Gains Momentum ↗
WW International (NASDAQ:WW) executives outlined the company’s efforts to reposition its weight-management business around behavioral support, telehealth and GLP-1 medications, following a... 
Via MarketBeat
Topics Supply Chain
News headline image
Stanley Black & Decker Targets Margin Gains as DEWALT Takes Share ↗
Stanley Black & Decker (NYSE:SWK) CEO Chris Nelson said the company is progressing against three priorities: strengthening its core brands, improving operational execution and accelerating innovation.... 
Via MarketBeat
News headline image
Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue Outlook ↗
Alnylam Pharmaceuticals (NASDAQ:ALNY) highlighted continued momentum for its AMVUTTRA treatment in transthyretin-mediated cardiomyopathy, while outlining a pipeline of upcoming clinical catalysts and... 
Via MarketBeat
News headline image
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets ↗
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare... 
Via MarketBeat
Topics ETFs
News headline image
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference ↗
IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product... 
Via MarketBeat
Topics ETFs
News headline image
Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent Loss ↗
Sanofi (NASDAQ:SNY) is prioritizing continued growth in Specialty Care while preparing for the loss of exclusivity of Dupixent in the early part of the next decade, according to Manuela Buxo, the... 
Via MarketBeat
Topics Intellectual Property
News headline image
Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing Push ↗
Pacific Biosciences of California (NASDAQ:PACB) is maintaining its existing strategy while sharpening execution around clinical genomics, cost controls and the rollout of products designed to improve... 
Via MarketBeat
News headline image
Rockwell Automation Sees Data Centers, Labor Crunch Fueling Automation Demand ↗
Rockwell Automation (NYSE:ROK) executives said customer sentiment remains broadly positive despite inflation, tariffs and trade-policy uncertainty, with manufacturers continuing to prioritize... 
Via MarketBeat
Topics Economy World Trade
News headline image
Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum Builds ↗
Cardinal Health (NYSE:CAH) CEO Jason Hollar said the company expects fiscal 2027 to extend the broad operating momentum it generated in fiscal 2026, with all five operating segments positioned for what... 
Via MarketBeat
Topics World Trade
News headline image
Boeing Isn't Perfect -- but It's Still a Compelling Value Buy Right Now ↗
Boeing's slow progress is not being recognized yet by the market. 
Via The Motley Fool
News headline image
Axsome Sees AUVELITY Prescriptions Accelerate as Alzheimer’s Launch Gains Traction ↗
Axsome Therapeutics (NASDAQ:AXSM) executives said the company is seeing accelerating prescription growth for AUVELITY following its sales-force expansion and the recent launch of the drug in... 
Via MarketBeat
News headline image
26 Analysts Covering SpaceX Stock Rate It a Buy. Here's Why 8 Analysts Disagree ↗
Wall Street remains very bullish on SpaceX stock. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
United Rentals Sees Large-Project Pipeline Accelerate as Specialty Demand Stays Strong ↗
United Rentals (NYSE:URI) executives said construction-equipment rental demand has exceeded the company’s expectations this year, led by an accelerating pipeline of large projects and supported by... 
Via MarketBeat
Topics Bonds Economy Energy
News headline image
Ionis Pharmaceuticals Eyes TRYNGOLZA Growth as Pipeline Faces Cardio Setbacks ↗
Ionis Pharmaceuticals (NASDAQ:IONS) CEO Brett Monia outlined recent regulatory wins, commercial-launch progress and several pipeline updates at the Morgan Stanley Global Healthcare Conference, while... 
Via MarketBeat
News headline image
Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances ↗
Intellia Therapeutics (NASDAQ:NTLA) executives outlined plans for a potential launch of its hereditary angioedema treatment, lonvo-z, while discussing the company’s ongoing Phase III program in... 
Via MarketBeat
Topics Intellectual Property
News headline image
BioCryst Eyes $1B Rare-Disease Future Through External Innovation ↗
BioCryst Pharmaceuticals (NASDAQ:BCRX) is shifting its strategy toward external innovation as it seeks to expand beyond its ORLADEYO hereditary angioedema, or HAE, franchise, newly appointed Chief... 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.